Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, today highlighted a key opinion leader presen ...
Dr. Sam Kim, Thoracic Surgeon at Northwestern Medicine Canning Thoracic Institute, joins Jon Hansen, filling in for Lisa Dent, to talk about meeting a six-year-old boy who wants to become a ...